Involvement of membrane-associated prostaglandin E synthase-1 in neovascularization.
Project/Area Number |
20590259
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
General pharmacology
|
Research Institution | Iwate Medical University |
Principal Investigator |
NARABA Hiroaki Iwate Medical University, 薬学部, 准教授 (90296517)
|
Project Period (FY) |
2008 – 2010
|
Project Status |
Completed (Fiscal Year 2010)
|
Budget Amount *help |
¥4,680,000 (Direct Cost: ¥3,600,000、Indirect Cost: ¥1,080,000)
Fiscal Year 2010: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2009: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2008: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
|
Keywords | 遺伝子発現 / 転写調節 / プロスタグランジン / シクロオキシゲナーゼ / 炎症性病態 / 新生血管 / 血管新生 / 癌 / 炎症 / 転写制御 |
Research Abstract |
Membrane-associated prostaglandin E_2 synthase (mPGES1) is an inducible terminal enzyme in the biosynthetic pathway for prostaglandin E_2, which participates in many biological processes such as neovascularization. We have already shown that Egr-1 is a key transcription factor in regulating the inducible expression of mPGES. In this study I have investigated the role of NAB2, a specific corepressor of EGR-1, to down-regulate growth factor-induced mPGES expression in inflammatory cells and to inhibit neovascularization. NAB2 was rapidly induced by increased levels of Egr-1 in vitro and in vivo model of neovascularization. Moreover, it was observed that the induction of mPGES1 gene expression and production of PGE_2 by treatment of siRNA specific for NAB2. These results suggest that NAB2 is involved in the regulation of the expression of mPGES1, and it may serve as a key molecule in the development and progression of neovascularization.
|
Report
(4 results)
Research Products
(11 results)